TEMP - Scientist, In Vivo Pharmacology (Immunology / Neuroimmunology) jobs in United States
cer-icon
Apply on Employer Site
company-logo

Neurocrine Biosciences · 2 hours ago

TEMP - Scientist, In Vivo Pharmacology (Immunology / Neuroimmunology)

Neurocrine Biosciences is a leading neuroscience-focused biopharmaceutical company dedicated to relieving suffering for people with great needs. The Scientist in In Vivo Pharmacology will perform experiments to support drug discovery efforts, focusing on in vivo and ex vivo studies related to immunology.

BiotechnologyHealth CarePharmaceutical
check
Comp. & Benefits
check
H1B Sponsor Likelynote

Responsibilities

Performs in vivo and ex-vivo studies to support scientific activities and project goals for immunology programs
Performs rodent handling and procedures including dosing (PO, SC, IP, IV, RO) and clinical health assessments
Contributes to study planning and works with cross-functional partners to align endpoints and timelines
Collects biologic samples and tissues; performs necropsy and tissue processing to support PK/PD, biomarker, and efficacy endpoints
Executes ex vivo cellular assays to interpret in vivo observations, including multiparametric flow cytometry and cytokine measurement assays
Operates and maintains laboratory equipment with accurate, timely record keeping; troubleshoots and recommends process improvements
Maintains and updates SOPs and writes data summaries/reports for experiments conducted
Actively participates in and presents to cross-departmental teams and meetings
Reviews, comprehends and complies with all SOPs, IACUC procedures, and safety and quality assurance standards at all times

Qualification

Vivo studiesRodent handlingFlow cytometryBiological sample collectionPharmacologyAnalytical thinkingMultitaskingProblem-solvingCommunication skillsDetail-oriented

Required

BS/BA degree in biological sciences preferably related to behavioral neuroscience, pharmacology or biopsychology and 2+ years of experience in the handling and dosing of rodents in a laboratory setting
MS/MA degree in biological sciences preferably related to behavioral neuroscience, pharmacology or biopsychology and some relevant experience preferred
PhD degree in biological sciences preferably related to behavioral neuroscience, pharmacology or biopsychology and some relevant experience preferred
Experience in executing pre-clinical in vivo studies and integrating PK with PD/efficacy
Strong knowledge of scientific principles, methods, and techniques
Strong communication, problem-solving, and analytical thinking skills
Ability to meet multiple deadlines with a high degree of accuracy and efficiency
Detail-oriented yet can see the broader picture of the scientific impact on the team
Adherence to good research practices and laboratory notebook/record-keeping
Advanced multitasking, troubleshooting, and deductive reasoning skills required
Strong interpersonal skills and the ability to excel in a highly collaborative environment
Willing to work some weekends and holidays as needed
Ability to work in a fast-paced environment and adapt to change

Preferred

Additional stereotaxic surgery, microdialysis and/or EEG experience strongly preferred
In vivo experience of autoimmune diseases and other inflammatory diseases is a plus
Also knowing how to develop animal disease models

Company

Neurocrine Biosciences

company-logo
Neurocrine Biosciences engages in the discovery and development of drugs for the treatment of neurological and endocrine-related diseases.

H1B Sponsorship

Neurocrine Biosciences has a track record of offering H1B sponsorships. Please note that this does not guarantee sponsorship for this specific role. Below presents additional info for your reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (16)
2024 (9)
2023 (8)
2022 (2)
2021 (5)
2020 (6)

Funding

Current Stage
Public Company
Total Funding
$260M
Key Investors
Venrock
2015-02-19Post Ipo Equity· $250M
2009-12-17Post Ipo Equity· $10M
1996-05-31IPO

Leadership Team

leader-logo
Matt Abernethy
Chief Financial Officer
linkedin
D
Dimitri Grigoriadis
VP, Research
linkedin
Company data provided by crunchbase